Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Botulinum Toxin Type A Treatment Report
What is Botulinum Toxin Type A?

Botulinum Toxin Type A is a neuromuscular blocker age. It is used to treat various types of dystonia (neurological movement disorders); for blepharospasm and strabismus; for primary axillary hyperhidrosis (excessive perspiration); and it is also used for cosmetic purposes.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Excess saliva 10 3
Stiffness/Spasticity 4 1
Other 3 0
Voice and speech problems 1 0
disease-related symptoms 1 0
Excessive daytime sleepiness (somnolence) 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 25%
Moderate
0 0%
Mild
1 25%
None
2 50%

Most commonly reported side effects

sub mandibular injection paralysed swallow muscles - terrible
1 25%
alligator tongue
1 25%
  • Mild
  • Moderate
  • Severe

Dosages

  0 as needed 100units as needed 10mg as needed 1 other as needed 200IU as needed as needed IU as needed 1 monthly 100 units monthly 100 units one time
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Botulinum Toxin Type A (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
2 40% Side effects too severe: 40%
Other
2 40% Other: 40%
Did not seem to work
1 20% Did not seem to work: 20%
Course of treatment ended
1 20% Course of treatment ended: 20%

See all 5 patients who’ve stopped taking Botulinum Toxin Type A

Currently Taking Botulinum Toxin Type A

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
1
4

Stopped Taking Botulinum Toxin Type A

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
1
2
0
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 25%
Usually
2 50%
Sometimes
1 25%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 25%
Somewhat
1 25%
A little
2 50%
Not at all
0 0%

Cost

Paid out of pocket

$200+
1 25%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.